NCT07233187

Brief Summary

This study is using Electronic Fetal Monitoring (EFM) to assess fetal health in pregnant women in labor. This will be compared with continuous wired EFM and continuous wireless EFM. The effects of wireless and continuous wireless EFM on labor pain levels and labor experiences will be measured.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
112

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 2, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

November 15, 2025

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 18, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 15, 2026

Completed
Last Updated

November 18, 2025

Status Verified

November 1, 2025

Enrollment Period

2 months

First QC Date

October 2, 2025

Last Update Submit

November 14, 2025

Conditions

Keywords

Fetal Monitoringintrapartumpainbirth experienceContinuous Wireless Fetal Monitoring

Outcome Measures

Primary Outcomes (2)

  • Birth Experience Questionnaire

    The Birth Experience Questionnaire (CEQ), developed by Dencker and colleagues in 2010, was adapted into Turkish by Mamuk and colleagues in 2019. Developed to measure women's birth experiences across various dimensions, the scale has four subscales and 22 items. It consists of the following subscales: Birth Process (8 items), Professional Assistance/Support (5 items), Perceived Safety/Memories (6 items), and Participation in Decisions (3 items).

    1 hour after the end of labor

  • The Visual Acuity Scale

    This is a horizontal or vertical line, usually 10 cm long, used to assess pain intensity. It begins with "No Pain" and ends with "Unbearable Pain." The patient marks the appropriate location on this line based on the pain they experience. The VAS is used to convert some values that cannot be measured numerically into numerical values. The two extremes of the parameter to be evaluated are written at either end of a 100 mm line, and the patient is asked to indicate where their own condition aligns with this line by drawing a line, placing a dot, or pointing. For example, for pain, "No pain at all" is written at one end, and "Extreme pain at the other end," and the patient marks their current condition on this line. According to this scale, the patient is asked to rate whether they have pain or not, and if so, to rate it on a scale of 0-10. According to this score, pain intensity is considered mild pain at \<3, moderate pain at 3-6, and severe pain at \>6. The distance from the point of

    Determining the pain level of pregnant women will be completed within 5 minutes when cervical dilation is 8-10 cm.

Secondary Outcomes (1)

  • Personal Information Form

    The data will be collected 5 minutes after the pregnant woman is included in the study.

Study Arms (2)

Continuous Wired EFM Group

NO INTERVENTION

In routine practice, fetal health assessments for pregnant women presenting for labor are conducted using a continuous wired EFM. Pregnant women in this group will not receive any interventions other than routine procedures. Because pregnant women are constantly connected to the EFM, the EFM will be removed and reconnected when necessary, such as when going to the toilet.

Continuous Wireless EFM Group

EXPERIMENTAL

Pregnant women in this group will be continuously assessed with wireless EFM. Because it's a wireless application, pregnant women will have the freedom to move freely throughout labor. They will be able to perform their own activities, such as toileting, and other necessary activities. Pregnant women will not be subjected to any other procedures other than continuous wireless EFM.

Other: Continuous Wireless EFM Group

Interventions

Pregnant women in this group will be continuously assessed with wireless EFM. Because it's a wireless application, pregnant women will have the freedom to move freely throughout labor. They will be able to perform their own activities, such as toileting, and other necessary activities. Pregnant women will not be subjected to any other procedures other than continuous wireless EFM.

Continuous Wireless EFM Group

Eligibility Criteria

Age19 Years - 35 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsSince the study will be conducted with pregnant women in the intrapartum period, only women will be biologically eligible to be included in the study.
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • The study included healthy primiparous or multiparous pregnant women who agreed to participate in the study, were between the ages of 18 and 35, had a gestational age greater than 37+0, had cervical dilation greater than 4 cm, had a single, live fetus, were not using uterotonic agents, spoke Turkish, had no comprehension, perception, or communication problems, and were healthy.

You may not qualify if:

  • Pregnant women who were diagnosed with a risky pregnancy, who were illiterate, who had a contagious disease, or who had a risky disease were not included in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tokat Gaziosmanpasa University

Tokat Province, Tokat Province, 60000, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Melek Şen Aytekin, Research Assistant

    Tokat Gaziosmanpasa University

    PRINCIPAL INVESTIGATOR
  • Demet Çakır, Assistant Professor

    Tokat Gaziosmanpasa University

    STUDY CHAIR
  • Ayşenur Kahraman, Research Assistant

    Tokat Gaziosmanpasa University

    STUDY CHAIR
  • Emine Aksüt Akçay

    Kahramanmaras Sütcü İmam Unıversity

    STUDY CHAIR

Central Study Contacts

Melek Şen Aytekin, Research Assistant Doctor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant Doctor

Study Record Dates

First Submitted

October 2, 2025

First Posted

November 18, 2025

Study Start

November 15, 2025

Primary Completion

January 15, 2026

Study Completion

January 15, 2026

Last Updated

November 18, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations